Pharmaceutical Network November 29 News In the first three quarters of this year, the pharmaceutical foreign trade in our country has enjoyed a good momentum of development. Market shares in mainstream markets such as Europe and the United States have become more and more stable. The implementation and promotion of the "One Belt and One Road Initiative" has expanded the market for our country's pharmaceutical products Demand, along the "Belt and Road" market share increased significantly.
Chinese medicine Health products According to the statistics of China Chamber of Commerce for Import and Export, in the first three quarters, China's pharmaceutical products were exported to 225 countries and regions. The major export markets are Asia, Europe and North America, with exports of 17.925 billion U.S. dollars, 11.42 billion U.S. dollars and 8.568 billion U.S. dollars respectively. The proportion is as high as 86.8% .European and North American countries are the main sources of import of pharmaceutical products in China, of which China's imports to North America increased by 17.73% over the same period of last year, while that of European imports increased by 18.05% over the same period of previous year.
In the first 9 months, the import and export of national pharmaceutical trade along the "Belt and Road" doubled up by 19.95% and 5.75% respectively from the previous year. Imports from Iran increased by 144.32% and imports from the Turkish market increased by 94.72%.
In an interview with International Business Daily during the 122nd Session of the Canton Fair, Meng Dongping, vice chairman of the Healthcare Business Association, said that the proposal of 'One Belt and One Road' initiative is not only for China medicine The industry has created more market space and released the attitude of the Chinese government toward inclusive cooperation. This positive signal has enabled markets around the world to adopt a more open and inclusive attitude to accept Chinese products and share China's reform and opening up The result.
In addition, Meng Dongping also pointed out that in the process, privately run enterprise , The performance of foreign-funded enterprises active, such enterprises because of flexible system, keen on the market, and timely adjustment of their business strategies and ideas, so in the process of international trade cooperation has shown its vitality.
According to reports, private enterprises and foreign-funded enterprises are the two main force in the foreign trade of medical insurance products in China.Export, from January to September, private-owned enterprises accounted for 79.62% of the total export enterprises, which completed 67.72% of the export volume and In terms of imports, foreign-funded enterprises accounted for 37.36% of total imports, taking 68.77% of imports and 61.05% of imports, while imports increased 19.34% over the same period of last year.
